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Article / Clinical Case Report
Abstract
Sporadic Burkitt lymphoma (SBL) is a variant of Burkitt lymphoma that occurs worldwide, affecting mainly children and 
young adults. Association with Epstein-Barr virus (EBV) can be identified in approximately 20-30% of cases. Herein 
we described a case of a 63-year-old male presenting intraoral bilateral mandibular swelling, subjacent to fixed dental 
prosthesis, with one month of duration. Incisional biopsies were performed, and after two days, the patient was hospitalized 
due to malaise and breathing difficulty, and died after a week when an abdominal tumor was detected. The mandibular 
biopsies revealed a diffuse proliferation of medium-sized monomorphic atypical lymphoid cells exhibiting numerous 
mitoses and areas of “starry-sky” pattern. The tumor showed immunohistochemical positivity for CD20, CD10, Bcl-6, and 
Ki-67 (≈ 100%); it was negative for CD3, Bcl-2, Vs38c, and MUM-1. Positivity for EBV was found by in situ hybridization. 
The final diagnosis was intraoral SBL positive for EBV. Clinical, morphological and molecular criteria are necessary for the 
correct diagnosis of aggressive B-cell neoplasms positive for EBV in elderly patients. 
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INTRODUCTION
Burkitt lymphoma (BL) is an aggressive B-cell 
lymphoma with three variants; endemic, sporadic, 
and immunodeficiency-associated, presenting specific 
epidemiologic and clinical features. Sporadic BL (SBL) 
occurs worldwide, being more common in children 
and young adults, rarely affecting elderly patients, 
who present significantly worse prognosis than the 
pediatric patients.1,2 Abdominal and ileocecal regions 
are the most frequent affected sites, while involvement 
of the oral cavity is rare.3
Approximately 20 to 30% of SBL cases are 
associated with Epstein-Barr virus (EBV), and 
Satou et al.4 indicated that the biological behavior and 
pathogenesis might be different between EBV positive 
and negative cases. BL usually present a translocation 
involving the MYC oncogene and it is composed by 
Intraoral EBV-positive sporadic Burkitt lymphoma in an elderly patient with bilateral presentation
2-7 Autops Case Rep (São Paulo). 2019 Oct-Dec;9(4):e2019117
monomorphic medium-sized cells, which are positive 
for CD10, CD20, CD22, CD79a, Bcl-6 and the 
proliferation index assessed by Ki-67 is nearly 100%.5
Despite the apparently well-defined features of 
BL, some non-Hodgkin lymphomas (NHL) such as 
diffuse large B-cell lymphoma (DLBCL), may present 
morphological, immunohistochemical and molecular 
similarities, becoming a diagnostic challenge;6,7 leading 
the World Health Organization (WHO) to include 
modifications in the classification to better characterize 
these lymphomas. High-grade B-cell lymphoma (HGBL) 
is another entity considered as differential diagnosis, 
since some of its morphological and molecular features 
can be present in BL and DLBCL.1
We herein describe a rare case of intraoral SBL 
in a 63-year-old Mexican male with bilateral lesions 
affecting the mandibular posterior alveolar ridge. 
The differential diagnosis with variants of DLBCL and 
HGBL is discussed.
CASE REPORT
A 63-year-old male patient was referred to dental 
service, presenting bilateral, painful erythematous 
mandibular swellings affecting the posterior alveolar 
ridges, at the level of the premolars on the left side 
(Figure 1A) and molars on the right side. The lesion 
was subjacent to fixed dental prosthesis, which caused 
compression and bleeding of the augmented soft 
tissue (Figure 1B). After removal of the dental fixed 
prosthesis, the lesion showed a rapid increase in size 
in a week (Figure 1C, 1D).
Incisional biopsies were performed in both sides 
under local anesthesia, and sent for histopathological 
study. However, after two days of the biopsy, the 
patient was hospitalized presenting malaise and 
breathing difficulties. By imaging studies, an abdominal 
tumor was detected, and patient died within 10 days. 
Microscopically, the oral lesions revealed a diffuse 
proliferation of monotonous, medium-sized lymphoid 
cells with scarce cytoplasm, round basophilic nuclei 
with fine chromatin, and multiple nucleoli. Nuclear 
pleomorphism, numerous mitotic and apoptotic 
figures were common (Figure 2A and B) including 
tingible body macrophages forming a “starry sky” 
pattern (Figure 2 C and D). The microscopical 
diagnosis of high-grade lymphoma was suggested. 
Immunohistochemistry and in situ hybridization (ISH) 
for EBV confirmed the diagnosis of SBL.
Immunohistochemically, the tumor was positive 
for CD20, CD10, Bcl-6, and for EBV-encoded RNA 
(EBER) by ISH (Figure 3A, 3B, 3C, 4A)¸ and negative for 
CD3, Bcl-2 (Figure 4B), Vs38c, and MUM-1. Ki67 index 
was near to 100% (Figure 3D). Based on histological 
and immunohistochemical findings, the final diagnosis 
(rendered postmortem) was of SBL.
DISCUSSION
NHL represent the second most common malignant 
tumor of the head and neck; comprising approximately 
3.5% of all oral cavity malignancies.8,9 Herein was 
described an unusual case of intraoral EBV-positive SBL 
in an elderly patient, discussing also the differential 
diagnosis between SBL and some aggressive B-cell 
lymphomas that were recently reclassified by the WHO.
Figure 1. Intraoral view of the lesion. A – bilateral, 
erythematous mandibular swelling affecting posterior 
alveolar ridges, at the level of premolars on the left side; 
B – Diffuse swelling involving the alveolar ridge at the 
molars level on the right side, subjacent to fixed dental 
prosthesis, which caused compression, and bleeding 
of the soft tissue swelling; C-D. The lesion showing a 
progressive increase after seven days of the dental fixed 
prosthesis removal.
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DLBCL and BL are B-cell lymphomas that may 
present clinical, morphological, immunohistochemical 
and molecular similarities, being difficult the correct 
diagnosis.7 Epidemiologically, DLBCL is more common 
in adult patients, unlike BL, which accounts for 30-40% 
of NHL in children.10 The main diagnostic hypotheses 
considered initially for this case were EBV-positive 
diffuse large B-cell lymphoma, not otherwise specified 
(EBV+ DLBCL NOS); HGBL, and BL.
DLBCL NOS is the most common subtype of 
lymphoma involving the oral cavity in adults, some 
cases presenting a germinal center phenotype (CD20+, 
CD10+, Bcl-6+, Bcl-2-, MUM-1- and Ki-67 >90%), which 
is similar to immunophenotypical expression of BL. 
Since our case presented EBV positivity, and the patient 
was elderly with no known history of immunodeficiency 
or prior lymphoma, EBV+ DLBCL NOS was considered 
as a differential diagnosis.11 Microscopically our case 
did not show the polymorphous cell variant, that 
consists in a mixture of small lymphocytes, plasma cells, 
histiocytes, proliferation of large transformed cells, 
and Hodgkin/Reed-Sternberg- like cells. However, it 
was similar with the monomorphic variant, but areas 
of geographic necrosis commonly seen in EBV+ DLBCL 
NOS was absent in the present case.1,11-15
Immunohistochemically, only CD20 would 
coincide between our case and EBV+ DLBCL NOS, 
since the last have a non-germinal center phenotype, 
Figure 2. Histopathological features of sporadic Burkitt lymphoma. A, B – diffuse proliferation of lymphoid cells, with 
scarce cytoplasm, and round nuclei (H&E, A:10x, B:20x); C – The lymphoid cells are medium sized with multiple and 
single evident nucleoli, nuclear pleomorphism, numerous mitotic and apoptotic figures (H&E, 40x); D – The tumor 
cells and tingible body macrophages showing a “starry sky” pattern; the lymphoid cells show fine, granular and 
dense chromatin (H&E, 40x).
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Figure 3. Immunohistochemical features of sporadic Burkitt lymphoma. Most tumor cells showed positivity for 
CD20 (A), Bcl-6 (B), CD10 (C), and the proliferation index assessed by Ki-67 near to 100% (D) (A-D: IHC, 40x).
Figure 4. In situ hybridization and immunohistochemical features of sporadic Burkitt lymphoma. A – The tumor was 
EBV positive (ISH-EBV, 40x); B – Bcl-2 was negative (IHC, 40x).
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being positive for MUM-1 and commonly negative for 
CD10 and Bcl-6.1 Nevertheless, a study demonstrated 
one case of EBV+ DLBCL NOS expressing CD10, and 
two cases being Bcl-6-positive and MUM-1 negative.12
HGBL has two categories, the first has intermediate 
features between DLBCL and BL,  present ing 
rearrangements of MYC/8q24 and Bcl-2/18q21, and/or 
Bcl-6/3q27, being so-called “double-hit” lymphomas 
(DHL) or “triple-hit” lymphomas (THL). Microscopically 
is characterized by a mixed population of intermediate 
to large transformed cells with apoptotic bodies, 
mitotic figures, and tingible body macrophages. 
Immunohistochemically, shows expression of CD19, 
CD20, CD79a, PAX5, CD10, and Bcl-6. DHL involving 
MYC and Bcl-2 cytogenetic abnormalities, exhibit 
strong expression of Bcl-2.1,11,16 The second category 
is the HGBL (NOS), and is composed of cells with 
blastoid appearance, resembling BL and DLBCL, but 
with absence of the genetic rearrangemets.1 Due the 
immunohistochemical and histopathological results 
of the present case, DHL was also considered in the 
differential diagnosis. However, the presence of EBV 
and negativity for Bcl-2 favors the diagnosis of BL.
Epidemiologically, endemic BL is more prevalent in 
children living in Africa; while SBL can occur worldwide 
also affecting mainly young patients being rare in 
the elderly. Gastrointestinal tract, abdomen, liver, 
oropharynx/nasopharynx, jaw/maxilla, ovaries, and 
central nervous system, are the predominant sites 
affected by SBL.17 According to the WHO criteria BL is 
characterized by a diffuse proliferation of monotonous, 
medium-sized lymphocytes with multiple nucleoli, and 
several mitotic figures, showing a “starry sky” pattern. 
BL is composed by mature B-cells positive for CD19, 
CD20, CD22 and CD79a, also exhibiting immunologic 
similarity to germinal center cells rather than activated 
B-cells, being also positive for Bcl-6, CD10 and 
negative for MUM-1, CD44, CD138 and Bcl-2.1 These 
findings are compatible with the present case, with 
the exception of EBV status, since only in geographic 
regions such as South Asia, Middle Eastern and 
South America, the EBV-positive BL rates are high 
(50-80%).17,18
Previously it was suggested that EBV-positive SBL 
constitute a distinct subgroup of BL, presenting some 
specific characteristics also found in our case: (1) less 
positivity for MUM1; (2) involvement of different 
anatomic topographies such as tonsils, adrenal gland, 
and cervical lymph nodes; (3) affect mainly patients 
older than 50 years and the frequency increases with 
age.4 The positivity of MUM-1 varies according to its 
origin, therefore, only a small group of BL originated 
from post-germinal center B cells shows positive 
expression. Despite MUM-1 is a potential adverse 
prognostic marker, its expression is not associated with 
EBV infection status.19
Although CD10-positivity can be seen in DLBCL 
NOS, the neoplastic cells are usually Bcl-2 positive 
and display a slightly lower Ki-67 proliferative index 
compared with BL that is close to 100%.7 Although the 
present case was not assessed for gene rearrangement 
and MYC immunohistochemical staining, there 
are cases in the literature without information 
about MYC gene rearrangement, and according to 
clinical, morphological and immunohistochemical 
characteristics were diagnosed as BL.20 It is well 
recognized that chromosomal translocations in the 
MYC oncogene are the biological hallmark of BL, 
but also may be present in other B-cell lymphomas; 
in this sense, when the morphological characteristics 
are compatible with BL, and the immunohistochemical 
findings show positivity for MYC and Bcl-2, it is 
recommended to perform molecular tests in the 
search for gene rearrangements to rule out DHL or 
THL.1,11,16 In this context, morphologic characteristics, 
Bcl-2 negativity, Ki-67>95% and EBV association, 
were the main features that supported the diagnosis 
of intraoral SBL.
Isolated oral SBL in adults is rare, with only few 
reports.21,22 Clinically, these lesions may resemble 
various oral pathologies¸ even of benign or reactive 
nature, including inflammatory periodontal processes.23 
Although our case had bilateral presentation and 
it was associated to fixed dental prosthesis, its 
aggressive features such as considerable size and rapid 
growth, raised the suspicion of malignancy, and the 
lesions were biopsied. Additionally, the patient was 
hospitalized for sudden worsening of his systemic 
condition, and full body computed tomography 
revealed an abdominal mass, which diagnosis was 
not confirmed, however, it is very likely to represent a 
manifestation of disseminated SBL, due to its location 
and clinical presentation. The patient died 10 days after 
the biopsies, confirming the aggressiveness, systemic 
involvement of the tumor, and the poor prognosis of 
BL in elderly patients.
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In summary, the role of the dentist is fundamental in 
early detection of primary and metastatic malignancies 
in the oral cavity, since the clinical spectrum can mimic 
benign or reactive conditions. Unfortunately, for most 
adult patients with BL, the prognosis remains poor 
despite therapy.
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